Skip to Content

Telaprevir use while Breastfeeding

Drugs containing Telaprevir: Incivek

Medically reviewed by Drugs.com. Last updated on Dec 26, 2020.

Telaprevir Levels and Effects while Breastfeeding

Summary of Use during Lactation

Telaprevir is not marketed in the United States and has not been studied in nursing mothers. Because it must be used with ribavirin and peginterferon alfa, it is not considered a good choice during breastfeeding. When it was marketed, the manufacturer recommended that mothers taking telaprevir not breastfeed their infants.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

(Hepatitis C) Interferon Alfa, Interferon Alfacon-1

Substance Identification

Substance Name

Telaprevir

CAS Registry Number

402957-28-2

Drug Class

Breast Feeding

Lactation

Antiviral Agents

Anti-Retroviral Agents

Anti-HIV Agents

Protease Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

More about telaprevir

Consumer resources

Other brands
Incivek

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.